RMTG · Regenerative Medical Technology Group Inc.
$0.10
+0.02 (+19.77%)
At close · Aug 31
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred losses since inception, resulting in an accumulated deficit of approximately $79,484,265 and a working capital deficit of $40,328,417 as of June 30, 2026, and future losses are anticipated. These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 19, 2026
Market Cap
$1.18M
Shares
13.74M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.10
Open$0.09
Day$0.09–0.10
52W close$0.02–0.12
Avg vol 30d128K
Short int9K · 0.1% float · 1.0d
Short vol58%
DataJan 2020–Aug 2026
Filing10-Q · Aug 19
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 19, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+110%
above
Price vs 50-day avg
+62%
above
RSI (14)
60
neutral
MACD trend
Positive
52-week position
83%
mid-range
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+47%
trailing
6-month return
+47%
trailing
YTD return
+110%
this year
Relative strength
+34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.06% of float · ▲ +8574.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
39
low risk · 0–100
Fundamentals
Revenue growth
+24%
Y/Y
Gross margin
55%
contracting
EPS growth
−41%
Y/Y
Free cash flow
$-1.3M
Quant / Vol
risk profile
Volatility
398%
annualized · 1-yr
Max drawdown
−74%
past year
ATR
19.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+110%
Bullish
Price vs 50-day avg
+62%
Bullish
RSI (14)
60
Neutral
MACD trend
Positive
Bullish
52-week position
83%
Neutral
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.06% of float · ▲ +8574.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 83%
Range high $0
vs 200-day avg +110%
vs 50-day avg +62%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RMTG
this stock
Regenerative Medical Technology Group Inc.
|
$1.18M | +110.2% | +24.2% | — | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +20.1% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +3.5% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$64.16B | +22.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.51B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RMTG | +14.4% | +47.1% | +47.1% | +52.1% | +110.2% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | +14.0% | +45.9% | +33.9% | +49.5% | +97.7% |